Creative Planning’s Mangoceuticals MGRX Stock Holding History

Creative Planning’s Portfolio MGRX Stock Details MGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,333	Closed	-$4.72K	–	3647
2024 Q3	$4.72K	Buy	+1,333	New	+$6.29K	﹤0.01%	3178

Other funds holding MGRX

ACA

Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Creative Planning's MGRX Position: Q4 2024 in Review

Creative Planning sold out of Mangoceuticals (MGRX) in Q4 2024, closing a stake of 1,333 shares — an estimated $4.72K sold.

Creative Planning first reported a position in MGRX in Q3 2024 and held it in 1 quarter. The position peaked at $4.72K in Q3 2024. 9 funds tracked by Wall St. Rank hold MGRX as of Q4 2024.

Creative Planning reported no remaining Mangoceuticals position as of Q4 2024 after selling out during the quarter.
Creative Planning sold 1,333 Mangoceuticals shares in Q4 2024, an estimated $4.72K.
Creative Planning first reported a position in Mangoceuticals in Q3 2024 and held it in 1 quarter.
Creative Planning's Mangoceuticals position peaked at $4.72K in Q3 2024.
9 funds tracked by Wall St. Rank held Mangoceuticals as of Q4 2024.

Based on Creative Planning's 13F filing for Q4 2024, filed 14 Feb 2025.